John Johnson

Director

John Johnson (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Axogen, Inc. (AXGN). The largest single filing was $1.4M of AXGN (45,379 sh across 4 lots, as filed), executed Dec 8 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.8M

shares × price, as filed

Last traded

May 7

Filed May 8

Median ADV $60.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

AXGN

Axogen, Inc. AXGN · 0 buys · 2 sells 2 filings XERS Xeris Biopharma Holdings, Inc. XERS · 0 buys · 2 sells 2 filings

Recent filings

AXGNSALE Axogen, Inc. View filing → $478K
11,050 sh × $43.26
Exec May 7
Filed May 8 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $978K
135,400 sh × $7.22
Exec Dec 19 2025
Filed Dec 19 2025 · 5:30 PM ET AXGNSALE Axogen, Inc. View filing → $1.4M
45,379 sh across 4 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $787K
107,500 sh × $7.32
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET